Results show that Nrf2 expression and its induction effect on GSH is pivotal in the inhibitory effect of SFN on bladder cancer cell growth by using Nrf2 siRNA and GSH-depleting agent BSO (Figure 3 and Figure 5). This evidence concerns the gene NFE2L2 and urinary bladder carcinoma.